INCYTE $20.36

down -1.05


19/6/2013 04:19 PM  |  NASDAQ : INCY  |  Industries : Professional, Scientific, and Technical Services / Scientific Research and Development Services
Get Trend Analysis Icon Get INCY Trend Analysis - it has underperformed the S&P 500 by 33%

Partner Headlines

  1. Mid-Afternoon Market Update: Bernanke Press Conference Leads to ...

    Benzinga

  2. Mid-Day Market Update: Fed to Continue Stimulus, Markets Rise

    Benzinga

  3. Gilead Acquiring YM Biosciences For Cancer Drug

    Investors Business Daily

  4. Incyte Achieves $50 Million Milestone as Oral JAK1/JAK2 Inhibitor ...

    Benzinga

  5. Incyte Corp. Reports Operating Results (10-Q)

    GuruFocus

  6. UPDATE: Bank of America Merrill Lynch Reiterates Buy Rating, ...

    Benzinga

  7. Benzinga's Top Initiations

    Benzinga

  8. Incyte Corp. Reports Operating Results (10-Q)

    GuruFocus

  9. Biotechs In Motion As New Drug Pipeline Brims

    Investors Business Daily

  10. Merck &, Questcor Pharmaceuticals, Other Stocks Hit 52-Week Highs ...

    FOXBusiness

  11. Lennar Corporation, D.R. Horton Among Stocks Hitting 52-Week Highs ...

    FOXBusiness

  12. Social Media Outlook for Tuesday July 3 (INCY, MCS, CLNE, OPEN)

    Benzinga

  13. Health Care Sector Wrap

    FOXBusiness

  14. Piper Jaffray Recommends Incyte (INCY)

    Benzinga

  15. Lilly and Incyte's Oral JAK1 and JAK2 Inhibitor, Baricitinib, ...

    Benzinga

  16. The Definitive Biotech ETF Guide (IBB, XBI, FBT)

    Benzinga

  17. S&P Bullish On Biotech ETFs (FBT, IBB, XBI)

    Benzinga

  18. Benzinga's Top Upgrades with Color for May 11, 2012

    Benzinga

  19. UPDATE: Goldman Sachs Upgrades Incyte; Raises PT

    Benzinga

  20. Benzinga's Top Upgrades

    Benzinga

  21. Brean Murray Carret & Co. Maintains Incyte Genomics at Buy, Lowers ...

    at Benzinga

  22. Notable Call Options Activity in Incyte

    at Benzinga

  23. Weekly Top Insider Buys: VTR, INCY, FULT, HMA, CMC

    at GuruFocus

  24. UPDATE: Bank of America Reports Development of New Incyte Model; ...

    at Benzinga

  25. 04 stocks with insider buying of more than $1.5 million since ...

    at GuruFocus

  26. Four stocks with insider buying of more than $1.5 million since ...

    at GuruFocus

  27. Benzinga's M&A Chatter for Tuesday January 17, 2012

    at Benzinga

  28. Benzinga's M&A Chatter for Thursday December 15, 2011

    at Benzinga

  29. Piper Jaffray Maintains Overweight, $23 Target on Incyte

    at Benzinga

  30. Benzinga's Volume Gainers

    at Benzinga

  31. Jefferies Maintains Buy Rating on Incyte

    at Benzinga

  32. Incyte (INCY) Down 0.2% as Put-Call Ratio Soars to 524

    At Market Intelligence Center
People viewing INCY also viewed: , , , , , ,
Marketplace
Trading Center